Article | August 25, 2021

Digital Transformation In Cell Therapy

Source: Cytiva

By Cytiva

iStock-1221576332-cell

To speed discovery and development and to create production process efficiencies, biopharmaceutical innovators are adopting machine learning, bioinformatics, and automation.

On a recent episode of The Business of Biotech, Dr. Mari Mitrani, co-founder and chief science officer of Organicell, and Dr. Michael Bellio, laboratory director, discussed how the clinical-stage regenerative medicine company has prioritized machine learning since its inception. Discover what they and other biopharmas are aiming to do with machine learning in the future.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: